Search

everythinglearnresearchcommunity

for

Search:↓

As skin cells mature, vitamin D receptor levels decrease while retinoid X receptor α levels increase.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

ILC1 cells contribute to hair loss in alopecia areata.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Fetal skin has unique immune cells different from adult skin.

Targeting specific T cells may help treat alopecia areata.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Some multiple sclerosis treatments may trigger hair loss conditions like alopecia areata.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.